Growth Factors of Medical Plastics Market
The medical plastics market has witnessed significant growth over the past decade, driven by technological advancements, increasing demand for healthcare products, and the global surge in medical plastic applications. The global market was valued at USD 29.93 billion in 2019 and is expected to reach USD 54.29 billion by 2027, growing at a compound annual growth rate (CAGR) of 7.1%. This growth can be attributed to the expanding healthcare industry and the growing demand for medical devices, instruments, and disposables made from plastics due to their unique characteristics, including lightweight, corrosion resistance, and sterilization compatibility.
Key Drivers of the Medical Plastics Market
1. Technological Advancements in Healthcare:
Technological innovations in medical devices and diagnostic instruments are major drivers of the medical plastics market. The trend toward miniaturization of devices, such as point-of-care diagnostics, wearable medical devices, and high-tech surgical tools, has increased the use of specialized medical plastics. These devices require materials that are not only durable but also able to withstand sterilization processes and provide a high degree of functionality.
Medical plastics are used in a wide range of applications, including diagnostic equipment, drug delivery systems, surgical tools, implants, and personal protective equipment (PPE). For instance, materials such as polycarbonate, polypropylene, and polyethylene are widely used in manufacturing MRI casings, surgical gloves, blood bags, catheters, and intravenous bags. These polymers offer the ideal balance between strength, flexibility, and chemical resistance, making them perfect for various medical applications.
2. Growing Demand for Disposable Medical Devices:
The healthcare sector’s increasing preference for disposable medical devices, particularly due to the growing concern about infection control and the ease of use, has also contributed significantly to the market expansion. The COVID-19 pandemic further fueled this demand, as global healthcare systems required vast amounts of disposable medical products such as masks, ventilators, and gloves, all of which rely heavily on medical-grade plastics.
The ability of medical plastics to be sterilized and their cost-effectiveness has also led to their widespread adoption in medical disposables. With an increasing number of surgeries, diagnostic tests, and hospital admissions, medical plastic products such as syringes, blood collection tubes, and drapes are essential for efficient healthcare delivery.
3. Environmental Considerations and Sustainability:
While the benefits of medical plastics are undeniable, the environmental concerns surrounding the disposal of single-use plastics have prompted a shift towards sustainable alternatives. Medical plastics, especially those used in single-use devices, contribute to a significant amount of waste. To address these concerns, many key players in the industry are focusing on developing bio-based, recyclable, and biodegradable plastics. Manufacturers are investing in research and development to create medical plastics that are both effective in healthcare applications and environmentally friendly.
Regional Market Insights
1. North America:
North America is one of the leading regions in the global medical plastics market. The region accounted for 17.91% of the market share in 2019. The U.S. is the largest contributor to this market, driven by high healthcare spending, advanced medical infrastructure, and a growing demand for healthcare devices and medical disposables. The increasing prevalence of chronic diseases and the aging population further propel the demand for advanced medical treatments and devices.
2. Asia-Pacific:
The Asia-Pacific region is expected to continue dominating the medical plastics market during the forecast period. Countries like China, India, and Japan are rapidly industrializing, and healthcare accessibility is improving. This is increasing the demand for healthcare services and medical devices. Additionally, the rise in medical tourism in countries like India and Thailand has increased the need for medical plastics, particularly in surgical instruments, diagnostic tools, and personal protective equipment.
3. Europe:
Europe also holds a significant share of the medical plastics market. The demand for medical plastics is driven by advancements in the healthcare sector, the presence of key pharmaceutical and medical device companies, and high per capita healthcare spending. Countries such as Germany, France, and the U.K. are leading contributors to the growth of the medical plastics market in the region.
Key Market Players
The market is highly competitive, with several leading players providing high-quality medical plastic materials and products. Key companies such as SABIC, Celanese Corporation, BASF SE, Evonik, and Covestro AG are at the forefront of the industry. These companies have a wide range of medical-grade plastics in their portfolios, which include solutions for drug delivery systems, surgical instruments, and medical packaging. Their strong distribution networks and strategic collaborations further strengthen their position in the market.
Conclusion
The medical plastics market is poised for substantial growth in the coming years, driven by technological advancements, increased healthcare demand, and the rising adoption of disposable medical devices. However, sustainability challenges related to waste management and the environmental impact of medical plastic disposal remain a concern. To ensure continued growth and environmental responsibility, the industry must invest in the development of recyclable and biodegradable medical plastics. As the demand for innovative medical solutions continues to rise globally, the medical plastics market will remain a vital component of the healthcare industry, playing a crucial role in the development of next-generation medical technologies.
ATTRIBUTE DETAILS
Study Period 2016-2027
Base Year 2019
Forecast Period 2020-2027
Historical Period 2016-2018
Unit Value (USD Billion), Volume (Kilo Tons)
Segmentation Application and Geography
By Application
Medical Disposables
Medical Instruments & Tools
Prosthetics & Implants
Drugs Packaging
Others
By Geography North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, and Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, South Korea, Singapore, and Rest of Asia- Pacific)
Latin America (Brazil, Mexico, Argentina, and Rest of South America)
The Middle East & Africa (South Africa, Egypt, Saudi Arabia, and Rest of Middle East & Africa)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Emerging Trends
- 4. Key Insights
- 4.1. Overview of the Parent/Related Markets
- 4.2. Industry SWOT Analysis
- 4.3. Regulatory Analysis
- 4.4. Recent Industry Developments - Policies, Partnerships, New Product Launches, and Mergers & Acquisitions
- 5. Global Medical Plastics Market Analysis, Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Size Estimates and Forecast
- 5.2.1. By Application (Volume/Value)
- 5.2.1.1. Medical Disposables
- 5.2.1.2. Medical Instruments
- 5.2.1.3. Prosthetics & Implants
- 5.2.1.4. Drugs Packaging
- 5.2.1.5. Others
- 5.2.2. By Region (Volume/Value)
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Latin America
- 5.2.2.5. Middle East & Africa
- 6. North America Medical Plastics Market Analysis, Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Size Estimates and Forecast
- 6.2.1. By Application (Volume/Value)
- 6.2.1.1. Medical Disposables
- 6.2.1.2. Medical Instruments
- 6.2.1.3. Prosthetics & Implants
- 6.2.1.4. Drugs Packaging
- 6.2.1.5. Others
- 6.2.2. By Country (Volume/Value)
- 6.2.2.1. U.S
- 6.2.2.1.1. By Application (Volume/Value)
- 6.2.2.1.1.1. Medical Disposables
- 6.2.2.1.1.2. Medical Instruments
- 6.2.2.1.1.3. Prosthetics & Implants
- 6.2.2.1.1.4. Drugs Packaging
- 6.2.2.1.1.5. Others
- 6.2.2.2. Canada
- 6.2.2.2.1. By Application (Volume/Value)
- 6.2.2.2.1.1. Medical Disposables
- 6.2.2.2.1.2. Medical Instruments
- 6.2.2.2.1.3. Prosthetics & Implants
- 6.2.2.2.1.4. Drugs Packaging
- 6.2.2.2.1.5. Others
- 7. Europe Medical Plastics Market Analysis, Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Size Estimates and Forecast
- 7.2.1. By Application (Volume/Value)
- 7.2.1.1. Medical Disposables
- 7.2.1.2. Medical Instruments
- 7.2.1.3. Prosthetics & Implants
- 7.2.1.4. Drugs Packaging
- 7.2.1.5. Others
- 7.2.2. By Country (Volume/Value)
- 7.2.2.1. Germany
- 7.2.2.1.1. By Application (Volume/Value)
- 7.2.2.1.1.1. Medical Disposables
- 7.2.2.1.1.2. Medical Instruments
- 7.2.2.1.1.3. Prosthetics & Implants
- 7.2.2.1.1.4. Drugs Packaging
- 7.2.2.1.1.5. Others
- 7.2.2.2. U.K.
- 7.2.2.2.1. By Application (Volume/Value)
- 7.2.2.2.1.1. Medical Disposables
- 7.2.2.2.1.2. Medical Instruments
- 7.2.2.2.1.3. Prosthetics & Implants
- 7.2.2.2.1.4. Drugs Packaging
- 7.2.2.2.1.5. Others
- 7.2.2.3. France
- 7.2.2.3.1. By Application (Volume/Value)
- 7.2.2.3.1.1. Medical Disposables
- 7.2.2.3.1.2. Medical Instruments
- 7.2.2.3.1.3. Prosthetics & Implants
- 7.2.2.3.1.4. Drugs Packaging
- 7.2.2.3.1.5. Others
- 7.2.2.4. Italy
- 7.2.2.4.1. By Application (Volume/Value)
- 7.2.2.4.1.1. Medical Disposables
- 7.2.2.4.1.2. Medical Instruments
- 7.2.2.4.1.3. Prosthetics & Implants
- 7.2.2.4.1.4. Drugs Packaging
- 7.2.2.4.1.5. Others
- 7.2.2.5. Spain
- 7.2.2.5.1. By Application (Volume/Value)
- 7.2.2.5.1.1. Medical Disposables
- 7.2.2.5.1.2. Medical Instruments
- 7.2.2.5.1.3. Prosthetics & Implants
- 7.2.2.5.1.4. Drugs Packaging
- 7.2.2.5.1.5. Others
- 7.2.2.6. Rest of Europe
- 7.2.2.6.1. By Application (Volume/Value)
- 7.2.2.6.1.1. Medical Disposables
- 7.2.2.6.1.2. Medical Instruments
- 7.2.2.6.1.3. Prosthetics & Implants
- 7.2.2.6.1.4. Drugs Packaging
- 7.2.2.6.1.5. Others
- 8. Asia-Pacific Medical Plastics Market Analysis, Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Size Estimates and Forecast
- 8.2.1. By Application (Volume/Value)
- 8.2.1.1. Medical Disposables
- 8.2.1.2. Medical Instruments
- 8.2.1.3. Prosthetics & Implants
- 8.2.1.4. Drugs Packaging
- 8.2.1.5. Others
- 8.2.2. By Country (Volume/Value)
- 8.2.2.1. China
- 8.2.2.1.1. By Application (Volume/Value)
- 8.2.2.1.1.1. Medical Disposables
- 8.2.2.1.1.2. Medical Instruments
- 8.2.2.1.1.3. Prosthetics & Implants
- 8.2.2.1.1.4. Drugs Packaging
- 8.2.2.1.1.5. Others
- 8.2.2.2. India
- 8.2.2.2.1. By Application (Volume/Value)
- 8.2.2.2.1.1. Medical Disposables
- 8.2.2.2.1.2. Medical Instruments
- 8.2.2.2.1.3. Prosthetics & Implants
- 8.2.2.2.1.4. Drugs Packaging
- 8.2.2.2.1.5. Others
- 8.2.2.3. Japan
- 8.2.2.3.1. By Application (Volume/Value)
- 8.2.2.3.1.1. Medical Disposables
- 8.2.2.3.1.2. Medical Instruments
- 8.2.2.3.1.3. Prosthetics & Implants
- 8.2.2.3.1.4. Drugs Packaging
- 8.2.2.3.1.5. Others
- 8.2.2.4. Australia
- 8.2.2.4.1. By Application (Volume/Value)
- 8.2.2.4.1.1. Medical Disposables
- 8.2.2.4.1.2. Medical Instruments
- 8.2.2.4.1.3. Prosthetics & Implants
- 8.2.2.4.1.4. Drugs Packaging
- 8.2.2.4.1.5. Others
- 8.2.2.5. Latin Korea
- 8.2.2.5.1. By Application (Volume/Value)
- 8.2.2.5.1.1. Medical Disposables
- 8.2.2.5.1.2. Medical Instruments
- 8.2.2.5.1.3. Prosthetics & Implants
- 8.2.2.5.1.4. Drugs Packaging
- 8.2.2.5.1.5. Others
- 8.2.2.6. Singapore
- 8.2.2.6.1. By Application (Volume/Value)
- 8.2.2.6.1.1. Medical Disposables
- 8.2.2.6.1.2. Medical Instruments
- 8.2.2.6.1.3. Prosthetics & Implants
- 8.2.2.6.1.4. Drugs Packaging
- 8.2.2.6.1.5. Others
- 8.2.2.7. Rest of Asia-Pacific
- 8.2.2.7.1. By Application (Volume/Value)
- 8.2.2.7.1.1. Medical Disposables
- 8.2.2.7.1.2. Medical Instruments
- 8.2.2.7.1.3. Prosthetics & Implants
- 8.2.2.7.1.4. Drugs Packaging
- 8.2.2.7.1.5. Others
- 9. Latin America Medical Plastics Market Analysis, Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Size Estimates and Forecast
- 9.2.1. By Application (Volume/Value)
- 9.2.1.1. Medical Disposables
- 9.2.1.2. Medical Instruments
- 9.2.1.3. Prosthetics & Implants
- 9.2.1.4. Drugs Packaging
- 9.2.1.5. Others
- 9.2.2. By Country (Volume/Value)
- 9.2.2.1. Brazil
- 9.2.2.1.1. By Application (Volume/Value)
- 9.2.2.1.1.1. Medical Disposables
- 9.2.2.1.1.2. Medical Instruments
- 9.2.2.1.1.3. Prosthetics & Implants
- 9.2.2.1.1.4. Drugs Packaging
- 9.2.2.1.1.5. Others
- 9.2.2.2. Mexico
- 9.2.2.2.1. By Application (Volume/Value)
- 9.2.2.2.1.1. Medical Disposables
- 9.2.2.2.1.2. Medical Instruments
- 9.2.2.2.1.3. Prosthetics & Implants
- 9.2.2.2.1.4. Drugs Packaging
- 9.2.2.2.1.5. Others
- 9.2.2.3. Argentina
- 9.2.2.3.1. By Application (Volume/Value)
- 9.2.2.3.1.1. Medical Disposables
- 9.2.2.3.1.2. Medical Instruments
- 9.2.2.3.1.3. Prosthetics & Implants
- 9.2.2.3.1.4. Drugs Packaging
- 9.2.2.3.1.5. Others
- 9.2.2.4. Rest of Latin America
- 9.2.2.4.1. By Application (Volume/Value)
- 9.2.2.4.1.1. Medical Disposables
- 9.2.2.4.1.2. Medical Instruments
- 9.2.2.4.1.3. Prosthetics & Implants
- 9.2.2.4.1.4. Drugs Packaging
- 9.2.2.4.1.5. Others
- 10. Middle East & Africa Medical Plastics Market Analysis, Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Size Estimates and Forecast
- 10.2.1. By Application (Volume/Value)
- 10.2.1.1. Medical Disposables
- 10.2.1.2. Medical Instruments
- 10.2.1.3. Prosthetics & Implants
- 10.2.1.4. Drugs Packaging
- 10.2.1.5. Others
- 10.2.2. By Country (Volume/Value)
- 10.2.2.1. Latin Africa
- 10.2.2.1.1. By Application (Volume/Value)
- 10.2.2.1.1.1. Medical Disposables
- 10.2.2.1.1.2. Medical Instruments
- 10.2.2.1.1.3. Prosthetics & Implants
- 10.2.2.1.1.4. Drugs Packaging
- 10.2.2.1.1.5. Others
- 10.2.2.2. Saudi Arabia
- 10.2.2.2.1. By Application (Volume/Value)
- 10.2.2.2.1.1. Medical Disposables
- 10.2.2.2.1.2. Medical Instruments
- 10.2.2.2.1.3. Prosthetics & Implants
- 10.2.2.2.1.4. Drugs Packaging
- 10.2.2.2.1.5. Others
- 10.2.2.3. Egypt
- 10.2.2.3.1. By Application (Volume/Value)
- 10.2.2.3.1.1. Medical Disposables
- 10.2.2.3.1.2. Medical Instruments
- 10.2.2.3.1.3. Prosthetics & Implants
- 10.2.2.3.1.4. Drugs Packaging
- 10.2.2.3.1.5. Others
- 10.2.2.4. Rest of Middle East & Africa
- 10.2.2.4.1. By Application (Volume/Value)
- 10.2.2.4.1.1. Medical Disposables
- 10.2.2.4.1.2. Medical Instruments
- 10.2.2.4.1.3. Prosthetics & Implants
- 10.2.2.4.1.4. Drugs Packaging
- 10.2.2.4.1.5. Others
- 11. Competitive Matrix
- 11.1. Business Strategies Adopted by Leading Players
- 11.2. Global Medical Plastics Market Revenue Share/Ranking Analysis, By Key Manufacturer
- 12. Company Profiles
- 12.1. SABIC
- 12.1.1. Overview
- 12.1.2. Description
- 12.1.3. Product Portfolio
- 12.1.4. Financials (Data as available in public domain and/or on paid databases)
- 12.1.5. Recent Developments
- 12.2. Celanese Corporation
- 12.2.1. Overview
- 12.2.2. Description
- 12.2.3. Product Portfolio
- 12.2.4. Financials (Data as available in public domain and/or on paid databases)
- 12.2.5. Recent Developments
- 12.3. BASF SE
- 12.3.1. Overview
- 12.3.2. Description
- 12.3.3. Product Portfolio
- 12.3.4. Financials (Data as available in public domain and/or on paid databases)
- 12.3.5. Recent Developments
- 12.4. Evonik
- 12.4.1. Overview
- 12.4.2. Description
- 12.4.3. Product Portfolio
- 12.4.4. Financials (Data as available in public domain and/or on paid databases)
- 12.4.5. Recent Developments
- 12.5. Covestro AG
- 12.5.1. Overview
- 12.5.2. Description
- 12.5.3. Product Portfolio
- 12.5.4. Financials (Data as available in public domain and/or on paid databases)
- 12.5.5. Recent Developments
- 12.6. Solvay
- 12.6.1. Overview
- 12.6.2. Description
- 12.6.3. Product Portfolio
- 12.6.4. Financials (Data as available in public domain and/or on paid databases)
- 12.6.5. Recent Developments
- 12.7. Röchling
- 12.7.1. Overview
- 12.7.2. Description
- 12.7.3. Product Portfolio
- 12.7.4. Financials (Data as available in public domain and/or on paid databases)
- 12.7.5. Recent Developments
- 12.8. GW Plastics
- 12.8.1. Overview
- 12.8.2. Description
- 12.8.3. Product Portfolio
- 12.8.4. Financials (Data as available in public domain and/or on paid databases)
- 12.8.5. Recent Developments
- 12.9. Nolato AB
- 12.9.1. Overview
- 12.9.2. Description
- 12.9.3. Product Portfolio
- 12.9.4. Financials (Data as available in public domain and/or on paid databases)
- 12.9.5. Recent Developments
- 12.10. Eastman Chemical Company
- 12.10.1. Overview
- 12.10.2. Description
- 12.10.3. Product Portfolio
- 12.10.4. Financials (Data as available in public domain and/or on paid databases)
- 12.10.5. Recent Developments
- 13. Appendix
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook